BROOKE SHELTON: Open Payments
NPI 1942999511 · PLEASANT GROVE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$460 in 23 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $94 · 2025 $460
Food & beverage: $460
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $86 |
| Phathom Pharmaceuticals, Inc. | 4 | $69 |
| Viatris Specialty LLC | 2 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Neuronetics, Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Tris Pharma Inc | 1 | $22 |
| Dexcom, Inc. | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
Products named: VOQUEZNA, VRAYLAR, YUPELRI, Kerendia, FARXIGA, NEUROSTAR TMS THERAPY SYSTEM, JARDIANCE, Dyanavel XR.
Industry payments across UT — which companies pay providers there.
